A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing

Zhenze Zhao1, Xiuye Ma2, Spencer D Shelton1

  • 1Department of Chemistry and Biochemistry at Texas State University, San Marcos, Texas, USA.

Oncotarget
|October 21, 2016
PubMed

Insights

MYCN amplification drives neuroblastoma. This study reveals a network where MYCN and differentiation-inducing microRNAs regulate tumor cell differentiation, impacting neuroblastoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MYCN amplification is a key driver of neuroblastoma tumorigenesis.
  • MYCN regulates cancer cell differentiation, a critical oncogenic mechanism.
  • MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer regulation.

Purpose of the Study:

  • To investigate the interaction network between MYCN and differentiation-inducing microRNAs in neuroblastoma.
  • To elucidate the role of this network in controlling neuroblastoma cell differentiation and tumorigenesis.

Main Methods:

  • Analysis of differentiation-inducing microRNAs targeting MYCN expression.
  • Investigation of MYCN-dependent and independent pathways in miRNA-mediated differentiation.
  • Correlation analysis of MYCN and miRNA expression in clinical neuroblastoma specimens.

Main Results:

  • Eight differentiation-inducing microRNAs were found to inhibit MYCN expression via direct or indirect mechanisms.
  • miR-506-3p and miR-449a demonstrated significant MYCN downregulation through distinct pathways.
  • MYCN was shown to inhibit the expression of multiple differentiation-inducing microRNAs.
  • Clinical data revealed significant inverse correlations between MYCN mRNA and miR-137/miR-2110 expression.

Conclusions:

  • MYCN and differentiation-inducing microRNAs form a regulatory network crucial for neuroblastoma cell differentiation.
  • This network plays a significant role in neuroblastoma tumorigenesis.
  • The identified interactions have potential clinical relevance for understanding neuroblastoma progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K